Revenues, Recognition and Allowances (Tables)

3 Months Ended

Mar. 31, 2019

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenues

Net revenues for the three months ended March 31, 2019 and 2018 were as follows:

	Three Months Ended March 31,
	2019		2018
Company product sales	$	12,495	$	13,236
Contract manufacturing sales	542		1,298
Research and development services and other income	85		11
Revenue, net	$	13,122	$	14,545

Disaggregated information for the Company product sales revenue has been recognized in the accompanying unaudited interim Condensed Consolidated Statements of Operations, and is presented below according to contract type:

	Three Months Ended March 31,
Company Product Sales	2019		2018
Topical	$	9,032	$	7,908
Injectables	3,463		5,328
Total	$	12,495	$	13,236

Schedule of Accounts, Notes, Loans and Financing Receivable

The Company's adjustments for the deductions to gross product sales are as follows:

	Three Months Ended March 31,
	2019		2018
Gross product sales	$	27,414	$	36,548
Deduction to gross product sales:
Chargebacks and billbacks	10,886		16,915
Wholesaler fees for service	1,766		635
Sales discounts and other allowances	2,267		5,762
Total reduction to gross product sales	$	14,919	$	23,312
Company product sales, net	$	12,495	$	13,236